Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

O Afolabi

Showing results (161-170 of 174) with videos related to

Pageof 18
Sort By:
Journal of Biomolecular Structure & Dynamics|May 31, 2022
Antimalarial phytochemicals as potential inhibitors of SARS-CoV-2 guanine N7-methyltransferase (nsp 14): an integrated computational approachGideon A Gyebi, Oludare M Ogunyemi, Adedotun A Adefolalu, et al.
BMJ Global Health|June 8, 2023
Addressing the challenges of implementing evidence-based prioritisation in global healthDavid T S Hayman, Rosemary K Barraclough, Louis J Muglia, et al.
West African Journal of Medicine|September 23, 2025
The Burden on Caregivers and Life Satisfaction Among Caregivers of Patients with Chronic Diseases Admitted to the Emergency Department of a Tertiary Health Institution in Southwest NigeriaO E Anjorin, S T Oladejo, M O Salami, et al.
Microbial Pathogenesis|August 1, 2024
Microbial mysteries: Staphylococcus aureus and the enigma of carcinogenesisTope T Odunitan, Boluwatife T Apanisile, Modinat W Akinboade, et al.
Current Research in Parasitology & Vector-Borne Diseases|October 13, 2025
Serological assessment of pediatric parasite exposure in two Senegalese districts using multiplex serologyHelena Brazal Monzó, Santiago Rayment Gomez, Doudou Sow, et al.
Emerging Infectious Diseases|February 24, 2022
Ebola Virus Glycoprotein IgG Seroprevalence in Community Previously Affected by Ebola, Sierra LeoneDaniela Manno, Philip Ayieko, David Ishola, et al.
Malaria Journal|November 14, 2023
Feasibility and safety of integrating mass drug administration for helminth control with seasonal malaria chemoprevention among Senegalese children: a randomized controlled, observer-blind trialMuhammed O Afolabi, Doudou Sow, Schadrac C Agbla, et al.
Frontiers in Immunology|December 8, 2017
Safety and Immunogenicity of Malaria Vectored Vaccines Given with Routine Expanded Program on Immunization Vaccines in Gambian Infants and Neonates: A Randomized Controlled TrialVictorine A Mensah, Sophie Roetynck, Ebrima K Kanteh, et al.
The Lancet. Infectious Diseases|September 16, 2021
Safety and immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in children in Sierra Leone: a randomised, double-blind, controlled trialMuhammed O Afolabi, David Ishola, Daniela Manno, et al.
The Lancet. Infectious Diseases|September 16, 2021
Safety and long-term immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in adults in Sierra Leone: a combined open-label, non-randomised stage 1, and a randomised, double-blind, controlled stage 2 trialDavid Ishola, Daniela Manno, Muhammed O Afolabi, et al.
Pageof 18

Showing results (161-170 of 174) with videos related to

Sort By:
Pageof 18
Journal of Biomolecular Structure & Dynamics|May 31, 2022
Antimalarial phytochemicals as potential inhibitors of SARS-CoV-2 guanine N7-methyltransferase (nsp 14): an integrated computational approachGideon A Gyebi, Oludare M Ogunyemi, Adedotun A Adefolalu, et al.
BMJ Global Health|June 8, 2023
Addressing the challenges of implementing evidence-based prioritisation in global healthDavid T S Hayman, Rosemary K Barraclough, Louis J Muglia, et al.
West African Journal of Medicine|September 23, 2025
The Burden on Caregivers and Life Satisfaction Among Caregivers of Patients with Chronic Diseases Admitted to the Emergency Department of a Tertiary Health Institution in Southwest NigeriaO E Anjorin, S T Oladejo, M O Salami, et al.
Microbial Pathogenesis|August 1, 2024
Microbial mysteries: Staphylococcus aureus and the enigma of carcinogenesisTope T Odunitan, Boluwatife T Apanisile, Modinat W Akinboade, et al.
Current Research in Parasitology & Vector-Borne Diseases|October 13, 2025
Serological assessment of pediatric parasite exposure in two Senegalese districts using multiplex serologyHelena Brazal Monzó, Santiago Rayment Gomez, Doudou Sow, et al.
Emerging Infectious Diseases|February 24, 2022
Ebola Virus Glycoprotein IgG Seroprevalence in Community Previously Affected by Ebola, Sierra LeoneDaniela Manno, Philip Ayieko, David Ishola, et al.
Malaria Journal|November 14, 2023
Feasibility and safety of integrating mass drug administration for helminth control with seasonal malaria chemoprevention among Senegalese children: a randomized controlled, observer-blind trialMuhammed O Afolabi, Doudou Sow, Schadrac C Agbla, et al.
Frontiers in Immunology|December 8, 2017
Safety and Immunogenicity of Malaria Vectored Vaccines Given with Routine Expanded Program on Immunization Vaccines in Gambian Infants and Neonates: A Randomized Controlled TrialVictorine A Mensah, Sophie Roetynck, Ebrima K Kanteh, et al.
The Lancet. Infectious Diseases|September 16, 2021
Safety and immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in children in Sierra Leone: a randomised, double-blind, controlled trialMuhammed O Afolabi, David Ishola, Daniela Manno, et al.
The Lancet. Infectious Diseases|September 16, 2021
Safety and long-term immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in adults in Sierra Leone: a combined open-label, non-randomised stage 1, and a randomised, double-blind, controlled stage 2 trialDavid Ishola, Daniela Manno, Muhammed O Afolabi, et al.
Pageof 18